Sol-Gel Technologies

+$0.13 (+1.16%) As of 5:38 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.

About SLGL

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.

CEO
Alon Seri-Levy
Employees
65
Headquarters
Ness Ziona, Tel Aviv
Founded
1997

SLGL Key Statistics

Market Cap
262.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
71.94K
High Today
$11.68
Low Today
$11.08
Open Price
$11.08
Volume
7.81K
52 Week High
$16.69
52 Week Low
$7.00

SLGL Earnings

-$0.47
-$0.31
-$0.16
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure